SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001640334-22-000200
Filing Date
2022-01-28
Accepted
2022-01-28 16:32:43
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3 lxrp_s3.htm S-3 210856
2 OPINION OF SICHENZIA ROSS FERENCE LLP lxrp_ex51.htm EX-5.1 23104
3 CONSENT OF DAVIDSON & COMPANY LLP lxrp_ex231.htm EX-23.1 3730
4 lxrp_ex51img2.jpg GRAPHIC 6027
5 lxrp_s3img3.jpg GRAPHIC 4782
6 lxrp_s3img4.jpg GRAPHIC 4782
  Complete submission text file 0001640334-22-000200.txt   260659
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: S-3 | Act: 33 | File No.: 333-262402 | Film No.: 22569338
SIC: 2834 Pharmaceutical Preparations